Sutro Biopharma STRO Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's enterprise value?
- Sutro Biopharma (STRO) reported enterprise value of $352.64M in Q1 2026.
- How has Sutro Biopharma's enterprise value changed year-over-year?
- Sutro Biopharma's enterprise value increased by 1262.8% year-over-year, from -$30.33M to $352.64M.
- What is the long-term trend for Sutro Biopharma's enterprise value?
- Over 5 years (2020 to 2025), Sutro Biopharma's enterprise value has grown at a -42.0% compound annual growth rate (CAGR), from $853.62M to $56.11M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.